PSQ Holdings, Inc. ("PublicSq."), the leading marketplace of
patriotic businesses and consumers, proudly announces the
commercial launch of its wholly-owned subsidiary EveryLife and its
first direct-to-consumer product offerings. EveryLife introduces a
line of premium baby products, including diapers and wipes,
dedicated to celebrating and protecting the miracle of every life.
The brand firmly believes that every individual, regardless of
their background, socioeconomic status, or circumstances of
conception, deserves love, support, and the right to life.
"The launch of EveryLife marks an exciting milestone for
PublicSq. As the nation’s leading values-aligned marketplace for
pro-family businesses and consumers, we have heard clearly through
searches on the PublicSq. platform that two of the products our
customers are seeking the most are diapers and wipes, a market
that, in the United States alone, represented more than $7B in
aggregate product sales in 2022.1 We believe the major incumbents
in this industry aren’t speaking to the values of a significant
number of Americans, so we have created a brand that will,” said
Michael Seifert, CEO and founder of PublicSq. "Through our growing
line of direct-to-consumer brands, we are empowering millions of
families to make a positive impact, support the values that our
business is built upon, and ensure that for every product, there’s
a patriotic, pro-family option.”
EveryLife distinguishes itself in the market by championing
parenthood and safeguarding life. The company's commitment to the
well-being of babies and their families is evident in its
meticulous selection of clean ingredients for its diapers and wipes
and prioritization of the use of safe, chemical-free materials that
do no harm to a baby's brain and development.
“We started our journey with input from a small group of parents
who are passionate about our faith, our families, and the inspiring
stories of expecting parents who boldly chose to protect the lives
of their babies,” said Caroline Carralero, CEO and co-founder of
EveryLife. “Our dedication lies in creating the highest quality,
clean baby products on the market at an accessible price point. In
addition to our product standards, we are equally passionate about
providing resources to expectant parents, empowering them to choose
life. The community we’re building aligns perfectly with
PublicSq.’s mission and values, and we’re proud to provide this
solution to its consumers.”
EveryLife's dedication to protecting life extends beyond product
formulation. The brand actively supports causes that advocate for
parenthood and the preservation of innocent life. To further their
mission, EveryLife intends to proudly donate a portion of its
proceeds to life-affirming organizations such as LiveAction and
Save The Storks, among others. EveryLife aims to provide expectant
mothers with the necessary support and resources that help them
make the brave and bold decision to choose life, especially in the
most challenging situations.
“The greatest joy in my life is being a father to three amazing
children,” added Nick Ayers, the co-founder of EveryLife. “We are
launching this company to give voice to the millions of Americans
who truly cherish every life, consider it a gift from above, and
want to do business with a company that shares their values.”
In contrast to major baby brands that endorse and financially
support abortion, EveryLife firmly believes that consumers deserve
the option to align their purchasing power with businesses that
share their values. By choosing EveryLife, consumers can actively
support pro-life initiatives while providing their families with
high-quality baby products.
July is a significant month for PublicSq., as it works toward
completion of its previously announced proposed business
combination with Colombier Acquisition Corp. (NYSE: CLBR), as a
result of which PublicSq. expects to become a publicly traded
company listed on the New York Stock Exchange and ring the opening
bell on July 20th.
To learn more about EveryLife and join the movement, visit the
official website at www.everylife.com.
About PublicSq. (PSQ Holdings, Inc.)
PublicSq. is an app and website that connects patriotic
Americans to high-quality businesses that share their values, both
online and in their local communities. The primary mission of the
platform is to help consumers "shop their values" and put purpose
behind their purchases. Since its nationwide launch, PublicSq. has
seen tremendous growth and proven to the nation that the parallel,
"patriotic" economy can be a major force in commerce. The platform
has over 55,000 businesses from a variety of different industries
and over 1.1 million active consumer members. It is free to join
for both consumers and business owners alike, and to learn more,
download the app on the App Store or Google Play, or visit
PublicSq.com.
About EveryLife Inc.
EveryLife Inc. began with a simple mission: to provide premium
products for every baby, because every baby is a miracle from God
who deserves to be loved, protected, and supported. At EveryLife,
we believe in providing for — and protecting — the next generation.
EveryLife Inc. was acquired by PublicSq. in February 2023 and
launched on July 13, 2023. To learn more, please visit
everylife.com.
Additional Information and Where to Find It
In connection with the proposed transaction (the “Proposed
Transaction”), Colombier has filed a registration statement on Form
S-4 (the “Registration Statement”) with, and now declared effective
by, the Securities and Exchange Commission (“SEC”), which includes
a preliminary proxy statement and a prospectus in connection with
the Proposed Transaction. STOCKHOLDERS OF COLOMBIER ARE ADVISED TO
READ, THE PRELIMINARY PROXY STATEMENT, ANY AMENDMENTS THERETO, THE
DEFINITIVE PROXY STATEMENT, THE PROSPECTUS AND ALL OTHER RELEVANT
DOCUMENTS FILED OR THAT WILL BE FILED WITH THE SEC IN CONNECTION
WITH THE PROPOSED TRANSACTION AS THEY BECOME AVAILABLE BECAUSE THEY
CONTAIN IMPORTANT INFORMATION. HOWEVER, THIS DOCUMENT WILL NOT
CONTAIN ALL THE INFORMATION THAT SHOULD BE CONSIDERED CONCERNING
THE PROPOSED TRANSACTION. IT IS ALSO NOT INTENDED TO FORM THE BASIS
OF ANY INVESTMENT DECISION OR ANY OTHER DECISION IN RESPECT OF THE
PROPOSED TRANSACTION. Now that the Registration Statement has been
declared effective, Colombier has mailed the definitive proxy
statement/prospectus and a proxy card to each stockholder of
Colombier as of the record date for the special meeting of
Colombier stockholders for voting on the Proposed Transaction.
Stockholders and other interested persons are also able to obtain
copies of the preliminary proxy statement/prospectus, the
definitive proxy statement/prospectus, the Registration Statement
and other documents filed by Colombier with the SEC that are
incorporated by reference therein, without charge, once available,
at the SEC’s website at www.sec.gov. Stockholders are urged to read
these materials (including any amendments or supplements thereto)
and any other relevant documents in connection with the Proposed
Transaction that Colombier has filed or will file with the SEC,
when they become available, because they do or will contain
important information about Colombier, PublicSq., and the Proposed
Transaction.
Colombier’s stockholders will also be able to obtain a copy of
such documents, without charge, by directing a request to:
Colombier Acquisition Corp., 214 Brazilian Avenue, Suite 200-J,
Palm Beach, FL 33480; e-mail: ir@colombierspac.com. These
documents, once available, can also be obtained, without charge, at
the SEC’s website www.sec.gov.
Participants in Solicitation
Colombier, PublicSq. and their respective directors and
executive officers may be deemed participants in the solicitation
of proxies of Colombier’s stockholders in connection with the
Proposed Transaction. Colombier’s stockholders and other interested
persons may obtain more detailed information regarding the names,
affiliations, and interests of certain of Colombier executive
officers and directors in the solicitation by reading Colombier’s
final prospectus filed with the SEC on June 9, 2021 in connection
with Colombier’s initial public offering, Colombier’s Annual Report
on Form 10-K for the year ended December 31, 2022, as filed with
the SEC on March 24, 2023 and Colombier’s other filings with the
SEC. A list of the names of such directors and executive officers
and information regarding their interests in the Proposed
Transaction, which may, in some cases, be different from those of
stockholders generally, are set forth in the Registration
Statement. These documents can be obtained free of charge from the
source indicated above.
No Offer or Solicitation
Neither the dissemination of this press release nor any part of
its contents is to be taken as any form of commitment on the part
of Colombier or PublicSq. or any of their respective affiliates to
enter any contract or otherwise create any legally binding
obligation or commitment. This press release shall not constitute
or form part of any offer or invitation to sell, or any
solicitation of a proxy, consent or authorization with respect to
any securities or in respect of the Proposed Transaction. This
press release shall not constitute an offer to sell or the
solicitation of an offer to buy any securities, nor shall there be
any sale of securities in any states or jurisdictions in which such
offer, solicitation or sale would be unlawful prior to registration
or qualification under the securities laws of such state or
jurisdiction. This press release is not, and under no circumstances
is to be construed as, a prospectus, a public offering, or an
offering memorandum as defined under applicable securities laws and
shall not form the basis of any contract. No offering of securities
shall be made except by means of a prospectus meeting the
requirements of Section 10 of the Securities Act of 1933, as
amended or an exemption therefrom.
Forward-Looking Statements
This communication may contain forward-looking statements within
the meaning of Section 27A of the Securities Act and Section 21E of
the Securities Exchange Act of 1934, as amended, and for purposes
of the “safe harbor” provisions under the United States Private
Securities Litigation Reform Act of 1995. Any statements other than
statements of historical fact contained herein are forward-looking
statements. Such forward-looking statements include, but are not
limited to, expectations, hopes, beliefs, intentions, plans,
prospects, financial results, or strategies regarding PublicSq.,
EveryLife and the Proposed Transaction and the future held by the
respective management teams of Colombier, PublicSq. or EveryLife,
the anticipated benefits and the anticipated timing of the Proposed
Transaction, future financial condition and performance of
PublicSq. and EveryLife, and expected financial impacts of the
Proposed Transaction (including future revenue, pro forma
enterprise value and cash balance), the satisfaction of closing
conditions to the Proposed Transaction, financing transactions, if
any, related to the Proposed Transaction, the level of redemptions
of Colombier’s public stockholders and the products and markets and
expected future performance and market opportunities of PublicSq.
and EveryLife. These forward-looking statements generally are
identified by the words “anticipate,” “believe,” “could,” “expect,”
“estimate,” “future,” “intend,” “may,” “might,” “strategy,”
“opportunity,” “plan,” “project,” “possible,” “potential,”
“project,” “predict,” “scales,” “representative of,” “valuation,”
“should,” “will,” “would,” “will be,” “will continue,” “will likely
result,” and similar expressions, but the absence of these words
does not mean that a statement is not forward-looking.
Forward-looking statements are predictions, projections and other
statements about future events that are based on current
expectations and assumptions and, as a result, are subject to risks
and uncertainties. Many factors could cause actual future events to
differ materially from the forward-looking statements in this
communication, including, without limitation: (i) the risk that the
Proposed Transaction may not be completed in a timely manner or at
all, which may adversely affect the price of Colombier’s
securities, (ii) the risk that the Proposed Transaction may not be
completed by Colombier’s business combination deadline and the
potential failure to obtain an extension of the business
combination deadline if sought by Colombier, (iii) the failure to
obtain the approval of the Proposed Transactions from the
stockholders of Colombier and PSQ, respectively, (iv) the failure
to obtain regulatory approvals, as applicable, required to
consummate the Proposed Transaction, (v) the occurrence of any
event, change or other circumstance that could give rise to the
termination of the Merger Agreement, (vi) the effect of the
announcement or pendency of the Proposed Transaction on PublicSq.’s
or EveryLife’s business relationships, operating results, and
business generally, (vii) risks that the Proposed Transaction
disrupts current plans and operations of PublicSq. and EveryLife,
(viii) the outcome of any legal proceedings that may be instituted
against PublicSq., EveryLife, or against Colombier related to the
Merger Agreement or the Proposed Transaction, (ix) the ability to
satisfy and maintain the listing of Colombier’s securities on the
New York Stock Exchange or another national securities exchange,
(x) changes in the competitive industries and markets in which
PublicSq. and EveryLife operate, variations in performance across
competitors, changes in laws and regulations affecting PublicSq.’s
and EveryLife’s business and changes in the combined capital
structure, (xi) the ability to implement business plans, growth,
marketplace and other expectations after the completion of the
Proposed Transaction, and identify and realize additional
opportunities, (xii) the potential inability of PublicSq. or
EveryLife to achieve their business and customer growth and
technical development plans, (xiii) the ability of PublicSq. and
EveryLife to enforce their current or future intellectual property,
including patents and trademarks, along with potential claims of
infringement by PublicSq. or EveryLife of the intellectual property
rights of others, (xiv) risk of loss of key influencers, media
outlets and promoters of PublicSq.’s and EveryLife’s business or a
loss of reputation of PublicSq. or EveryLife or reduced interest in
the mission and values of PublicSq. and EveryLife, and the segment
of the consumer marketplace they intend to serve and (xv) the risk
of economic downturn, increased competition, a changing regulatory
landscape and related impacts that could occur in the highly
competitive consumer marketplace, both online and through “bricks
and mortar” operations. The foregoing list of factors is not
exhaustive. Recipients should carefully consider such factors and
the other risks and uncertainties described and to be described in
the “Risk Factors” section of Colombier’s IPO prospectus filed with
the SEC on June 9, 2021, Colombier’s Annual Report on Form 10-K
filed for the year ended December 31, 2022, as filed with the SEC
on March 24, 2023, and subsequent periodic reports filed by
Colombier with the SEC, the Registration Statement and other
documents filed or to be filed by Colombier from time to time with
the SEC. These filings identify and address other important risks
and uncertainties that could cause actual events and results to
differ materially from those contained in the forward-looking
statements. Forward-looking statements speak only as of the date
they are made. Recipients are cautioned not to put undue reliance
on forward-looking statements, and neither PublicSq. nor EveryLife,
nor Colombier assume any obligation to, nor intend to, update or
revise these forward-looking statements, whether as a result of new
information, future events, or otherwise, except as required by
law. Neither PublicSq., nor EveryLife, nor Colombier gives any
assurance that either PublicSq., EveryLife, or Colombier, or the
combined company, will achieve its expectations.
Information Sources; No Representations
This press release has been prepared for use by Colombier and
PublicSq. in connection with the Proposed Transaction. The
information therein does not purport to be all-inclusive. The
information therein is derived from various internal and external
sources, with all information relating to the business, past
performance, results of operations and financial condition of
Colombier derived entirely from Colombier and all information
relating to the business, past performance, results of operations
and financial condition of PublicSq. derived entirely from
PublicSq. No representation is made as to the reasonableness of the
assumptions made with respect to the information therein, or to the
accuracy or completeness of any projections or modeling or any
other information contained therein. Any data on past performance
or modeling contained therein is not an indication as to future
performance.
No representations or warranties, express or implied, are given
in respect of the communication. To the fullest extent permitted by
law, under no circumstances will Colombier or PublicSq., or any of
their respective subsidiaries, affiliates, shareholders,
representatives, partners, directors, officers, employees, advisors
or agents, be responsible or liable for any direct, indirect or
consequential loss or loss of profit arising from the use of the
this communication (including without limitation any projections or
models), any omissions, reliance on information contained within
it, or on opinions communicated in relation thereto or otherwise
arising in connection therewith, which information relating in any
way to the operations of PublicSq. has been derived, directly or
indirectly, exclusively from PublicSq. and has not been
independently verified by Colombier. Neither the independent
auditors of Colombier nor the independent auditors of PublicSq.
audited, reviewed, compiled or performed any procedures with
respect to any projections or models for the purpose of their
inclusion in the communication and, accordingly, neither of them
expressed any opinion or provided any other form of assurances with
respect thereto for the purposes of the communication.
1 Source: Statista Market Insights
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230713144309/en/
For Investors: Longacre Square Partners
IRCLBR@longacresquare.com
For Media: JCONNELLY psq@jconnelly.com
Colombier Acquisition (NYSE:CLBR)
過去 株価チャート
から 11 2024 まで 12 2024
Colombier Acquisition (NYSE:CLBR)
過去 株価チャート
から 12 2023 まで 12 2024
